{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:42:16Z","timestamp":1792226536035,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1111\/dsu.12060","type":"journal-article","created":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T14:18:34Z","timestamp":1356531514000},"page":"435-442","source":"Crossref","is-referenced-by-count":97,"title":["Oral Tranexamic Acid Enhances the Efficacy of Low-Fluence 1064-Nm Quality-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial"],"prefix":"10.1097","volume":"39","author":[{"given":"Jung U","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ho","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210206","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma. Etiologic and therapeutic considerations.","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"R3-14-20210206","doi-asserted-by":"crossref","first-page":"191S","DOI":"10.1038\/jid.1993.12","article-title":"Influence of inflammatory mediators and cytokines on human melanocyte function.","volume":"100","author":"Morelli","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R4-14-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.det.2007.04.006","article-title":"Therapeutical approaches in melasma.","volume":"25","author":"Prignano","year":"2007","journal-title":"Dermatol Clin"},{"key":"R5-14-20210206","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials.","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R6-14-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5173(01)00980-2","article-title":"Development of novel topical tranexamic acid liposome formulations.","volume":"235","author":"Manosroi","year":"2002","journal-title":"Int J Pharm"},{"key":"R7-14-20210206","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00042728-200605000-00004","article-title":"Localized intradermal microinjection of tranexamic acid for treatment of melasma in asian patients: a preliminary clinical trial.","volume":"32","author":"Lee","year":"2006","journal-title":"Dermatol Surg"},{"key":"R9-14-20210206","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","article-title":"Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.","volume":"64","author":"Pandya","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R10-14-20210206","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaad.2005.12.039","article-title":"Treatment of melasma.","volume":"54","author":"Rendon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R11-14-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/09546631003686051","article-title":"Efficacy of the 1064nm Qswitched Nd:YAG laser in melasma.","volume":"22","author":"Suh","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"R12-14-20210206","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1524-4725.2011.02001.x","article-title":"Efficacy and safety of Qswitched 1,064nm neodymiumdoped yttrium aluminum garnet laser treatment of melasma.","volume":"37","author":"Zhou","year":"2011","journal-title":"Dermatol Surg"},{"key":"R13-14-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1524-4725.2011.02147.x","article-title":"Lowfluence Qswitched 1,064nm neodymiumdoped yttrium Aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.","volume":"38","author":"Lee","year":"2012","journal-title":"Dermatol Surg"},{"key":"R14-14-20210206","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications.","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"R15-14-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1684\/ejd.2010.0912","article-title":"Tranexamic acid can treat ultraviolet radiationinduced pigmentation in guinea pigs.","volume":"20","author":"Li","year":"2010","journal-title":"Eur J Dermatol"},{"key":"R16-14-20210206","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1538-7836.2004.00694.x","article-title":"Plasminogen regulates proopiomelanocortin processing.","volume":"2","author":"Wang","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R17-14-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1346-8138.2007.00307.x","article-title":"New approach to the evaluation of skin color of pigmentary lesions using Skin Tone Color Scale.","volume":"34","author":"Konishi","year":"2007","journal-title":"J Dermatol"},{"key":"R18-14-20210206","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/14764172.2011.630084","article-title":"Treatment of melasma with low fluence, large spot size, 1064nm Qswitched neodymiumdoped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types IIIV.","volume":"13","author":"Brown","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"R19-14-20210206","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1524-4725.2011.01957.x","article-title":"A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after qswitched ruby laser.","volume":"37","author":"Kato","year":"2011","journal-title":"Dermatol Surg"},{"key":"R20-14-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/14764172.2011.630088","article-title":"Melasma: treatment strategy.","volume":"13","author":"Sehgal","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"R21-14-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09546631003801619","article-title":"Glutathione as an oral whitening agent: a randomized, doubleblind, placebocontrolled study.","volume":"23","author":"Arjinpathana","year":"2012","journal-title":"J Dermatolog Treat"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1111\/dsu.12060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:07:29Z","timestamp":1620979649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201303010-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1111\/dsu.12060","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}